Skip to main content
Diabetes Care logoLink to Diabetes Care
. 2016 Sep 13;39(10):1846. doi: 10.2337/dc16-er10

Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes

J Michael Gaziano, Anthony H Cincotta, Christopher M O’Connor, Michael Ezrokhi, Dean Rutty, ZJ Ma, Richard E Scranton
PMCID: PMC6908412  PMID: 27660123

In Table 2 of the article cited above, there is an error in the calculation of the percent of subjects meeting a study end point. The placebo value for “Hospitalization for congestive heart failure” is 6 (0.4) in the original table presentation. The correct value is 6 (0.6).

The section of the corrected table is presented below.

Composite CVD End Point by Each Component‡
Myocardial infarction 7 (0.3) 9 (0.9)
Stroke 5 (0.2) 6 (0.6)
Hospitalization for unstable angina 9 (0.4) 9 (0.9)
Hospitalization for congestive heart failure 9 (0.4) 6 (0.6)
Coronary revascularization 11 (0.5) 8 (0.8)

Articles from Diabetes Care are provided here courtesy of American Diabetes Association

RESOURCES